Leber Laura

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2019-10-21	2019-10-17	Genomic Health Inc (GHDX)	PlS Planned sale	77,934 +27.2% 464.43 US$3,832,758	77,934 +27.2%	464.43	US$3,832,758
2019-02-22	2019-02-21	Genomic Health Inc (GHDX)	PlS Planned sale	39,235 -9.3% 71.71 US$4,700,060	39,235 -9.3%	71.71	US$4,700,060
2019-02-22	2019-02-21	Genomic Health Inc (GHDX)	PlS Planned sale	34,437 -18.6% 419.24 US$2,574,042	34,437 -18.6%	419.24	US$2,574,042
2019-02-22	2019-02-21	Genomic Health Inc (GHDX)	PlS Planned sale	1,067 -4.7% 85.47 US$91,192	1,067 -4.7%	85.47	US$91,192
2019-02-22	2019-02-20	Genomic Health Inc (GHDX)	PlS Planned sale	3,271 -13.6% 83.50 US$273,119	3,271 -13.6%	83.50	US$273,119
2019-02-22	2019-02-20	Genomic Health Inc (GHDX)	PlS Planned sale	15,479 -39.1% 82.74 US$1,280,705	15,479 -39.1%	82.74	US$1,280,705